Long-term results of pars plana vitrectomy as an anti-inflammatory therapy of pediatric intermediate uveitis resistant to standard medical treatment

Eur J Ophthalmol. 2018 Jan;28(1):98-102. doi: 10.5301/ejo.5001020. Epub 2018 Feb 19.


Purpose: To evaluate the efficacy of pars plana vitrectomy (PPV) as an anti-inflammatory therapy in pediatric recurrent intermediate uveitis.

Methods: A retrospective study evaluated the long-term results of PPV indicated for intermediate uveitis with a mean observation period of 10.3 years (range 7-15.6 years) in 6 children (mean age 8 years, range 6-12 years). Pars plana vitrectomy was performed on 10 eyes in the standard manner and was initiated by vitreous sampling for laboratory examination. Data recorded were perioperative or postoperative vitrectomy complications, anatomic and functional results of PPV, and preoperative and postoperative best-corrected Snellen visual acuity.

Results: No perioperative or postoperative complications were observed. Bacteriologic, virologic, mycotic, and cytologic analysis of the vitreous was negative in all tested children. Five eyes were subsequently operated on for posterior subcapsular cataracts. An average preoperative visual acuity of 0.32 improved to an average postoperative visual acuity of 0.8.

Conclusions: In the case of systemic immunosuppressive treatment failure in pediatric uveitis, particularly in eyes with cystoid macular edema, we recommend PPV relatively early.

Keywords: Intermediate pediatric uveitis; Long-term results; Pars plana vitrectomy; Vitreous analysis.

MeSH terms

  • Adolescent
  • Anti-Inflammatory Agents / therapeutic use*
  • Child
  • Female
  • Follow-Up Studies
  • Forecasting*
  • Humans
  • Male
  • Postoperative Period
  • Recurrence
  • Retrospective Studies
  • Treatment Outcome
  • Uveitis, Intermediate / diagnosis
  • Uveitis, Intermediate / drug therapy
  • Uveitis, Intermediate / surgery*
  • Visual Acuity*
  • Vitrectomy / methods*


  • Anti-Inflammatory Agents